This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1995 Jun:2 Suppl 2:23-35.

Intravesical chemotherapy and immunotherapy: how do we assess their effectiveness and what are their limitations and uses?

D L Lamm¹, A P van der Meijden, H Akaza, C Brendler, P O Hedlund, Y Mizutani, T L Ratliff, M R Robinson, T Shinka

Affiliations

PMID: 7553302

Free article

Review

Intravesical chemotherapy and immunotherapy: how do we assess their effectiveness and what are their limitations and uses?

D L Lamm et al. Int J Urol. 1995 Jun.

Free article

. 1995 Jun:2 Suppl 2:23-35.

Authors

D L Lamm¹, A P van der Meijden, H Akaza, C Brendler, P O Hedlund, Y Mizutani, T L Ratliff, M R Robinson, T Shinka

Affiliation

¹ West Virginia University Health Science Center, Department of Urology, Morgantown 26506, USA.

PMID: 7553302

No abstract available

PubMed Disclaimer

Similar articles

Intravesical therapy for superficial bladder cancer.
Malkowicz SB. Malkowicz SB. Semin Urol Oncol. 2000 Nov;18(4):280-8. Semin Urol Oncol. 2000. PMID: 11101091 Review.
Risk-adapted use of intravesical immunotherapy.
Braasch MR, Böhle A, O'Donnell MA. Braasch MR, et al. BJU Int. 2008 Nov;102(9 Pt B):1254-64. doi: 10.1111/j.1464-410X.2008.07968.x. BJU Int. 2008. PMID: 19035890 Review. No abstract available.
Impact of intravesical chemotherapy versus BCG immunotherapy on recurrence of superficial transitional cell carcinoma of the bladder: metaanalytic reevaluation.
Huncharek M, Kupelnick B. Huncharek M, et al. Am J Clin Oncol. 2003 Aug;26(4):402-7. doi: 10.1097/01.COC.0000026911.98171.C6. Am J Clin Oncol. 2003. PMID: 12902895
Risk-adapted use of intravesical chemotherapy.
Lerner SP, Au JL. Lerner SP, et al. BJU Int. 2008 Nov;102(9 Pt B):1247-53. doi: 10.1111/j.1464-410X.2008.07967.x. BJU Int. 2008. PMID: 19035889 No abstract available.
High-risk superficial bladder cancer: intravesical therapy for T1 G3 transitional cell carcinoma of the urinary bladder.
Pham HT, Soloway MS. Pham HT, et al. Semin Urol Oncol. 1997 Aug;15(3):147-53. Semin Urol Oncol. 1997. PMID: 9394909 Review.

See all similar articles

Cited by

Prognostic impact of Bacillus Calmette-Guérin interruption at the time of induction and consolidation.
Alhogbani MM, Picard JA, Fassi-Fehri MH, Badet JL, Colombel CM. Alhogbani MM, et al. Urol Ann. 2017 Oct-Dec;9(4):315-320. doi: 10.4103/UA.UA_115_17. Urol Ann. 2017. PMID: 29118530 Free PMC article.
Non-specific immunotherapy with bacille Calmette-Guérin (BCG).
van der Meijden AP. van der Meijden AP. Clin Exp Immunol. 2001 Feb;123(2):179-80. doi: 10.1046/j.1365-2249.2001.01449.x. Clin Exp Immunol. 2001. PMID: 11252346 Free PMC article. Review. No abstract available.
In vitro synergistic cytotoxicity of gemcitabine and pemetrexed and pharmacogenetic evaluation of response to gemcitabine in bladder cancer patients.
Mey V, Giovannetti E, De Braud F, Nannizzi S, Curigliano G, Verweij F, De Cobelli O, Pece S, Del Tacca M, Danesi R. Mey V, et al. Br J Cancer. 2006 Aug 7;95(3):289-97. doi: 10.1038/sj.bjc.6603242. Epub 2006 Jul 25. Br J Cancer. 2006. PMID: 16868547 Free PMC article. Clinical Trial.
Immunotherapy for superficial bladder cancer.
Schenk-Braat EA, Bangma CH. Schenk-Braat EA, et al. Cancer Immunol Immunother. 2005 May;54(5):414-23. doi: 10.1007/s00262-004-0621-x. Epub 2004 Nov 23. Cancer Immunol Immunother. 2005. PMID: 15565330 Free PMC article. Review.
Nanocarrier mediated delivery of siRNA/miRNA in combination with chemotherapeutic agents for cancer therapy: current progress and advances.
Gandhi NS, Tekade RK, Chougule MB. Gandhi NS, et al. J Control Release. 2014 Nov 28;194:238-56. doi: 10.1016/j.jconrel.2014.09.001. Epub 2014 Sep 7. J Control Release. 2014. PMID: 25204288 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Wiley
Medical
- MedlinePlus Health Information